What are the targeted treatments for lung cancer

Targeted therapy for lung cancer

1. In the treatment of lung cancer, targeted therapy has gradually attracted attention. This treatment is similar to chemotherapy in that it is also a drug treatment. However, targeted therapy is more targeted than chemotherapy.

2. Targeted therapy is a therapeutic drug designed at the cellular and molecular level for specific carcinogenic sites. The drug will specifically select carcinogenic sites to combine and act. It causes cancer cells to die specifically without affecting normal tissues. Targeted therapy has been widely used in clinical practice.

3. Molecular targeted therapy has huge advantages compared with traditional chemotherapy.

Personalized treatment becomes possible

For example, the efficacy of EGFR-TKI treatment for non-small cell lung cancer with EGFR mutations is over 90%, so tissue EGFR testing can predict the efficacy of treatment.

Target specificity and mild side effects

Unlike cytotoxic chemotherapy, targeted drugs often act on abnormal mutation sites, have specific targets, and have little impact on normal tissue cells. Therefore, gastrointestinal reactions and hematological toxicity are relatively mild and easier for patients to tolerate.

The treatment method is simple and easy

Nowadays, many targeted drugs are taken orally, and patients have good compliance and tolerance. They can be administered in outpatient clinics and at home, and patients are easily accepted.

Improved quality of life

For patients with advanced tumors, cytotoxic drugs can prolong the survival of some patients, but the side effects are serious, which makes patients afraid of treatment. Targeted drugs can usually quickly improve patients' symptoms and have few side effects.

Molecular targeted drugs combined with chemotherapy can improve efficacy

For example, the combination of anti-angiogenic drugs and chemotherapy can significantly improve the efficacy without significantly increasing toxic side effects.